Join us at our complimentary webinar on ‘IP Valuation and Mergers & Acquisitions (M&A) with a Focus on BioTech and Life Science’ on Wednesday, 18 March.

Hear from Aon IP experts who will share key insights on areas such as drug formula patents, medical devices (including testing equipment), patents/trade secrets, as well as various risk mitigation tools relating to M&A activities in the biotechnology and life science industry.

The webinar will focus on:
• Management of IP portfolio
• Third-party IP claims
• Key drivers behind the IP valuation
• Mitigation of regulatory and transaction risks of M&A